Physician profile
Xiaolin Yu
NPI 1861717779
$707.27
in general payments reported to CMS, 2019-2025
11 companies · $75.79 in 2025
The $75.79 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $72.94 · 2021: $72.83 · 2022: $86.76 · 2023: $82.64 · 2025: $75.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $274.01 | 2019-2023 | Xarelto |
| Pfizer INC. | $113.39 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $77.83 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $74.10 | 2020-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $64.00 | 2019-2023 | |
| Abbott Laboratories | $28.89 | 2022 | |
| Insmed, INC. | $18.79 | 2025 | Arikayce |
| Abbvie INC. | $15.00 | 2021 | |
| Gilead Sciences, INC. | $14.06 | 2021 | |
| Ucb, INC. | $13.64 | 2020 | |
| Shire North American Group INC | $13.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaolin Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.